MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Daiwa Securities Starts Merck & Co. at Neutral With $70 Price Target

12/16/2021 | 06:53am EDT


© MT Newswires 2021
All news about MERCK & CO., INC.
05/20Merck's Keytruda Receives Positive EMA Panel Opinion as Adjuvant Therapy in Skin Cancer
MT
05/20Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treat..
BU
05/20Merck Gets CHMP Backing for Expanded Keytruda Use in Melanoma
DJ
05/17Calliditas Therapeutics Starts Enrollment of Mid-Stage Head and Neck Cancer Study
MT
05/17Berenberg Bank Adjusts Merck's Price Target to $95 From $87, Maintains Hold Rating
MT
05/16Neoleukin Therapeutics Treats First Tumor Patient in Trial Evaluating NL-201 With Keytr..
MT
05/16Athenex, Merck Collaborate to Study Oraxol Plus Keytruda in Non-Small Cell Lung Cancer
MT
05/16Athenex, Inc. Announces Clinical Collaboration with Merck to Evaluate Oraxol Plus KEYTR..
CI
05/16Rising Cyber Attacks Could Make Insurance Unaffordable
AQ
05/13Tesla, Occidental rise; New Relic, Merck fall
AQ
More news
Analyst Recommendations on MERCK & CO., INC.
More recommendations
Financials (USD)
Sales 2022 57 865 M - -
Net income 2022 15 443 M - -
Net Debt 2022 17 730 M - -
P/E ratio 2022 15,3x
Yield 2022 2,98%
Capitalization 237 B 237 B -
EV / Sales 2022 4,39x
EV / Sales 2023 4,32x
Nbr of Employees 67 500
Free-Float 70,6%
Chart MERCK & CO., INC.
Duration : Period :
Merck & Co., Inc. Technical Analysis Chart | MRK | US58933Y1055 | MarketScreener
Technical analysis trends MERCK & CO., INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 93,55 $
Average target price 95,54 $
Spread / Average Target 2,13%
EPS Revisions
Managers and Directors
Robert M. Davis President, Chief Executive Officer & Director
Caroline A. Litchfield Chief Financial Officer & Executive Vice President
Kenneth C. Frazier Executive Chairman
Dave Williams EVP, Chief Information & Digital Officer
Lisa LeCointe-Cephas Chief Ethics & Compliance Officer, SVP
Sector and Competitors
1st jan.Capi. (M$)
MERCK & CO., INC.22.06%236 570
JOHNSON & JOHNSON1.68%465 705
PFIZER, INC.-11.14%294 404
ELI LILLY AND COMPANY8.19%269 013
ABBVIE INC.11.53%266 851
ROCHE HOLDING AG-15.67%266 707